FY2025
Effective from
- Inherited rules changed
Type 2 diabetes mellitus with other specified complications
Category — select a more specific code
CDC/NCHS · FY2025For US diagnosis claims covered by HIPAA, ICD-10-CM is required from October 1, 2015.
Use the service date for outpatient/professional claims and the discharge date for hospital inpatient claims. Earlier encounters use ICD-9-CM; each individual code must also be valid for the applicable date.
Official coding guidelines → · CMS ↗First observed · 2015-10-01
Latest recorded change · FY2025
Effective from
Type 2 diabetes mellitus with other specified complications
Category — select a more specific code
CDC/NCHS · FY2025| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | Inherited rules changed |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | Inherited rules changed |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
The official Tabular List has no additional instructions at this code level.
Review the instructions inherited from its parent categories below. Inherited instructions ↓
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
E11.61Type 2 diabetes mellitus with diabetic arthropathyCategory · further specificity requiredE11.62Type 2 diabetes mellitus with skin complicationsCategory · further specificity requiredE11.63Type 2 diabetes mellitus with oral complicationsCategory · further specificity requiredE11.64Type 2 diabetes mellitus with hypoglycemiaCategory · further specificity requiredE11.65Type 2 diabetes mellitus with hyperglycemiaBillable / specificE11.69Type 2 diabetes mellitus with other specified complicationBillable / specificOther entries in the same category; these are not automatic substitutes.
| Code | Description | Category · further specificity required |
|---|---|---|
| E11.0 | Type 2 diabetes mellitus with hyperosmolarity | Category · further specificity required |
| E11.1 | Type 2 diabetes mellitus with ketoacidosis | Category · further specificity required |
| E11.2 | Type 2 diabetes mellitus with kidney complications | Category · further specificity required |
| E11.3 | Type 2 diabetes mellitus with ophthalmic complications | Category · further specificity required |
| E11.4 | Type 2 diabetes mellitus with neurological complications | Category · further specificity required |
| E11.5 | Type 2 diabetes mellitus with circulatory complications | Category · further specificity required |
| E11.8 | Type 2 diabetes mellitus with unspecified complications | Billable / specific |
| E11.9 | Type 2 diabetes mellitus without complications | Billable / specific |
| E11.A | Type 2 diabetes mellitus without complications in remission | Billable / specific |
Official titles and instructions are preserved in their source language. Official sources ↗